JP6987393B2 - 血液中の無細胞ｄｎａを用いた血液学的障害の検出 - Google Patents

血液中の無細胞ｄｎａを用いた血液学的障害の検出 Download PDF

Info

Publication number
JP6987393B2
JP6987393B2 JP2018562945A JP2018562945A JP6987393B2 JP 6987393 B2 JP6987393 B2 JP 6987393B2 JP 2018562945 A JP2018562945 A JP 2018562945A JP 2018562945 A JP2018562945 A JP 2018562945A JP 6987393 B2 JP6987393 B2 JP 6987393B2
Authority
JP
Japan
Prior art keywords
dna
cell
methylation
plasma
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018562945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524056A (ja
JP2019524056A5 (https=
Inventor
ユイク−ミーン デニス ロ
ロッサ ワイ クーン チーウ
クワン チー チャン
クン スン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese University of Hong Kong CUHK
Original Assignee
Chinese University of Hong Kong CUHK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese University of Hong Kong CUHK filed Critical Chinese University of Hong Kong CUHK
Publication of JP2019524056A publication Critical patent/JP2019524056A/ja
Publication of JP2019524056A5 publication Critical patent/JP2019524056A5/ja
Priority to JP2021189986A priority Critical patent/JP7537758B2/ja
Application granted granted Critical
Publication of JP6987393B2 publication Critical patent/JP6987393B2/ja
Priority to JP2024019464A priority patent/JP7819956B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2018562945A 2016-05-30 2017-05-30 血液中の無細胞ｄｎａを用いた血液学的障害の検出 Active JP6987393B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021189986A JP7537758B2 (ja) 2016-05-30 2021-11-24 血液中の無細胞ｄｎａを用いた血液学的障害の検出
JP2024019464A JP7819956B2 (ja) 2016-05-30 2024-02-13 血液中の無細胞ｄｎａを用いた血液学的障害の検出

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662343050P 2016-05-30 2016-05-30
US62/343,050 2016-05-30
PCT/CN2017/086509 WO2017206888A1 (en) 2016-05-30 2017-05-30 Detecting hematological disorders using cell-free dna in blood

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021189986A Division JP7537758B2 (ja) 2016-05-30 2021-11-24 血液中の無細胞ｄｎａを用いた血液学的障害の検出

Publications (3)

Publication Number Publication Date
JP2019524056A JP2019524056A (ja) 2019-09-05
JP2019524056A5 JP2019524056A5 (https=) 2020-07-09
JP6987393B2 true JP6987393B2 (ja) 2021-12-22

Family

ID=60479040

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018562945A Active JP6987393B2 (ja) 2016-05-30 2017-05-30 血液中の無細胞ｄｎａを用いた血液学的障害の検出
JP2021189986A Active JP7537758B2 (ja) 2016-05-30 2021-11-24 血液中の無細胞ｄｎａを用いた血液学的障害の検出
JP2024019464A Active JP7819956B2 (ja) 2016-05-30 2024-02-13 血液中の無細胞ｄｎａを用いた血液学的障害の検出

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021189986A Active JP7537758B2 (ja) 2016-05-30 2021-11-24 血液中の無細胞ｄｎａを用いた血液学的障害の検出
JP2024019464A Active JP7819956B2 (ja) 2016-05-30 2024-02-13 血液中の無細胞ｄｎａを用いた血液学的障害の検出

Country Status (13)

Country Link
US (3) US10781490B2 (https=)
EP (3) EP3885447B1 (https=)
JP (3) JP6987393B2 (https=)
KR (4) KR20260023093A (https=)
CN (2) CN109196120B (https=)
AU (2) AU2017274038B2 (https=)
CA (1) CA3025708A1 (https=)
DK (2) DK3885447T3 (https=)
ES (1) ES3060334T3 (https=)
IL (2) IL303115B2 (https=)
SG (1) SG11201810544WA (https=)
TW (2) TW202426661A (https=)
WO (1) WO2017206888A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
EP3885447B1 (en) 2016-05-30 2024-01-10 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood
KR20260032575A (ko) 2016-11-30 2026-03-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
SG11201906397UA (en) 2017-01-25 2019-08-27 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments
CN111051536A (zh) 2017-07-26 2020-04-21 香港中文大学 利用不含细胞的病毒核酸改善癌症筛选
WO2019173283A1 (en) 2018-03-05 2019-09-12 Marquette University Method and apparatus for non-invasive hemoglobin level prediction
US12098429B2 (en) 2019-03-25 2024-09-24 The Chinese University Of Hong Kong Determining linear and circular forms of circulating nucleic acids
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法
CN115175985A (zh) * 2019-12-20 2022-10-11 威廉马歇莱思大学 从未经处理的生物样本中提取单链dna和rna并测序的方法
GB2598272A (en) * 2020-03-19 2022-03-02 Schreier Stefan Means and method for detecting aberrant erythroblasts
EP3905260A1 (en) * 2020-04-28 2021-11-03 Sysmex Corporation Method, apparatus and system for testing blood
CN111518876B (zh) * 2020-05-11 2023-01-13 润方（北京）生物医药研究院有限公司 一种牛血红蛋白制品中牛源基因组dna定量检测方法及其应用
KR102517894B1 (ko) * 2021-02-23 2023-04-04 연세대학교 산학협력단 당뇨발에 의한 하지 절단 수술의 치료 반응성을 예측하는 방법
CN120089209B (zh) * 2025-05-08 2025-12-05 中国科学院北京基因组研究所(国家生物信息中心) 鉴定肿瘤诱导产生的有核红细胞的方法和装置

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1342794T3 (da) 2002-03-05 2006-04-24 Epigenomics Ag Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
WO2007050706A2 (en) 2005-10-27 2007-05-03 University Of Missouri-Columbia Dna methylation biomarkers in lymphoid and hematopoietic malignancies
US20090176655A1 (en) * 2007-11-16 2009-07-09 Oncomethylome Sciences Sa Methylation detection
US9023819B2 (en) * 2008-06-09 2015-05-05 National Chung Cheng University Treatment of a disease or a condition associated with aberrant gene hypomethylation by a method involving tailored epigenomic modification
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
WO2011092592A2 (en) 2010-01-26 2011-08-04 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
PL2558854T3 (pl) 2010-04-16 2019-04-30 Chronix Biomedical Biomarkery będące krążącymi kwasami nukleinowymi związanymi z rakiem piersi
CN105243295B (zh) 2010-11-30 2018-08-17 香港中文大学 与癌症相关的遗传或分子畸变的检测
US20120190020A1 (en) 2011-01-25 2012-07-26 Aria Diagnostics, Inc. Detection of genetic abnormalities
CN102206708B (zh) * 2011-03-29 2014-05-28 北京大学 一种检测血液中转移肝癌细胞的试剂盒、标志物及方法
US10752953B2 (en) 2011-05-12 2020-08-25 The Johns Hopkins University Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof
US20140178348A1 (en) 2011-05-25 2014-06-26 The Regents Of The University Of California Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
CN113355321A (zh) 2011-09-26 2021-09-07 凯杰有限公司 用于分离细胞外核酸的快速方法
EP2768985B1 (en) 2011-10-21 2019-03-20 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
US20130122492A1 (en) * 2011-11-14 2013-05-16 Kellbenx Inc. Detection, isolation and analysis of rare cells in biological fluids
SI4056712T1 (sl) * 2012-09-20 2024-10-30 The Chinese University Of Hong Kong Neinvazivno določanje metiloma tumorja iz plazme
US9732390B2 (en) * 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20130189684A1 (en) 2013-03-12 2013-07-25 Sequenom, Inc. Quantification of cell-specific nucleic acid markers
US20160340740A1 (en) 2014-01-30 2016-11-24 The Regents Of The University Of California Methylation haplotyping for non-invasive diagnosis (monod)
WO2015159292A2 (en) 2014-04-14 2015-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A method and kit for determining the tissue or cell origin of dna
JP6681841B2 (ja) 2014-05-09 2020-04-15 ライフコーデックス アーゲー 特別な細胞タイプに由来するｄｎａの検出とそれに関連する方法
KR101598371B1 (ko) * 2014-07-14 2016-02-29 브릴리언츠 주식회사 스마트멀티카드
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
EP3885447B1 (en) 2016-05-30 2024-01-10 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood

Also Published As

Publication number Publication date
TW201800754A (zh) 2018-01-01
JP2019524056A (ja) 2019-09-05
KR20230164209A (ko) 2023-12-01
KR102482616B1 (ko) 2022-12-28
JP7537758B2 (ja) 2024-08-21
EP3885447B1 (en) 2024-01-10
KR20190013878A (ko) 2019-02-11
DK3464637T3 (da) 2021-07-26
CN115161390B (zh) 2025-12-05
CN115161390A (zh) 2022-10-11
US20200385811A1 (en) 2020-12-10
DK3885447T3 (da) 2024-04-15
IL262953B2 (en) 2023-11-01
EP3885447A1 (en) 2021-09-29
CA3025708A1 (en) 2017-12-07
US20240229103A1 (en) 2024-07-11
US11873527B2 (en) 2024-01-16
EP4324937B1 (en) 2026-01-21
EP4324937A3 (en) 2024-05-15
WO2017206888A1 (en) 2017-12-07
EP4324937A2 (en) 2024-02-21
EP3464637A1 (en) 2019-04-10
US10781490B2 (en) 2020-09-22
AU2017274038A1 (en) 2018-12-06
KR20260023093A (ko) 2026-02-20
TWI838330B (zh) 2024-04-11
IL303115B1 (en) 2025-05-01
AU2017274038B2 (en) 2023-03-16
IL303115B2 (en) 2025-09-01
KR102605504B1 (ko) 2023-11-22
AU2023203305A1 (en) 2023-06-22
EP3464637B1 (en) 2021-06-23
SG11201810544WA (en) 2018-12-28
CN109196120B (zh) 2022-08-02
KR102922179B1 (ko) 2026-02-02
KR20230003666A (ko) 2023-01-06
US20170349948A1 (en) 2017-12-07
JP7819956B2 (ja) 2026-02-25
IL262953B1 (en) 2023-07-01
IL303115A (en) 2023-07-01
IL262953A (en) 2018-12-31
EP3464637A4 (en) 2019-12-11
ES3060334T3 (en) 2026-03-25
CN109196120A (zh) 2019-01-11
EP4324937C0 (en) 2026-01-21
JP2022024127A (ja) 2022-02-08
JP2024054311A (ja) 2024-04-16
TW202426661A (zh) 2024-07-01

Similar Documents

Publication Publication Date Title
JP7819956B2 (ja) 血液中の無細胞ｄｎａを用いた血液学的障害の検出
CN106661609B (zh) 用于预测先天性心脏缺陷的方法
HK40081560A (en) Detecting hematological disorders using cell-free dna in blood
HK40060886B (en) Detecting hematological disorders using cell-free dna in blood
HK40060886A (en) Detecting hematological disorders using cell-free dna in blood
HK1261820A1 (en) Detecting hematological disorders using cell-free dna in blood
HK1261820B (en) Detecting hematological disorders using cell-free dna in blood
HK1262491B (en) Detecting hematological disorders using cell-free dna in blood
HK1237826B (zh) 用於预测先天性心脏缺陷的方法
HK1237826A1 (en) Method for predicting congenital heart defect

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200529

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200529

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20201223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210119

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210603

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211026

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211124

R150 Certificate of patent or registration of utility model

Ref document number: 6987393

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250